TY - JOUR
T1 - Waist circumference cut-off points to identify major cardiovascular events and incident diabetes in Latin America
T2 - findings from the prospective Urban rural epidemiology study Colombia
AU - Lopez-Lopez, Jose P.
AU - Gonzalez, Ana María
AU - Lanza, Paola
AU - Martinez-Bello, Daniel
AU - Gomez-Arbelaez, Diego
AU - Otero, Johanna
AU - Cohen, Daniel D.
AU - Perez-Mayorga, Maritza
AU - Garcia-Peña, Angel A.
AU - Rangarajan, Sumathy
AU - Yusuf, Salim
AU - Lopez-Jaramillo, Patricio
N1 - Publisher Copyright:
2023 Lopez-Lopez, Gonzalez, Lanza, Martinez-Bello, Gomez-Arbelaez, Otero, Cohen, Perez-Mayorga, Garcia-Peña, Rangarajan, Yusuf and Lopez-Jaramillo.
PY - 2023
Y1 - 2023
N2 - Background: Abdominal obesity (AO) indirectly represents visceral adiposity and can be assessed by waist circumference (WC) measurement. In Latin America, cut-off points for the diagnosis of AO are based on Asian population data. We aim to establish the WC cut-off points to predict major cardiovascular events (MACE) and incident diabetes. Methods: We analyzed data from the cohort PURE study in Colombia. WC cut-off points were defined according to the maximum Youden index. Multivariate logistic regression was used to obtain associations between WC and MACE, diabetes, and cumulative incidence of outcomes visualized using Kaplan-Meier curves. Results: After a mean follow-up of 12 years, 6,580 individuals with a mean age of 50.7 ± 9.7 years were included; 64.2% were women, and 53.5% were from rural areas. The mean WC was 85.2 ± 11.6 cm and 88.3 ± 11.1 cm in women and men, respectively. There were 635 cases of the MACE composite plus incident diabetes (5.25 events per 1,000 person-years). Using a cut-off value of 88.85 cm in men (sensitivity = 0.565) and 85.65 cm in women (sensitivity = 0.558) resulted in the highest value for the prediction of the main outcome. These values were associated with a 1.76 and 1.41-fold increased risk of presenting the composite outcome in men and women, respectively. Conclusions: We defined WC cut-off points of 89 cm in men and 86 cm in women to identify the elevated risk of MACE and incident diabetes. Therefore, we suggest using these values in cardiovascular risk assessment in Latin America.
AB - Background: Abdominal obesity (AO) indirectly represents visceral adiposity and can be assessed by waist circumference (WC) measurement. In Latin America, cut-off points for the diagnosis of AO are based on Asian population data. We aim to establish the WC cut-off points to predict major cardiovascular events (MACE) and incident diabetes. Methods: We analyzed data from the cohort PURE study in Colombia. WC cut-off points were defined according to the maximum Youden index. Multivariate logistic regression was used to obtain associations between WC and MACE, diabetes, and cumulative incidence of outcomes visualized using Kaplan-Meier curves. Results: After a mean follow-up of 12 years, 6,580 individuals with a mean age of 50.7 ± 9.7 years were included; 64.2% were women, and 53.5% were from rural areas. The mean WC was 85.2 ± 11.6 cm and 88.3 ± 11.1 cm in women and men, respectively. There were 635 cases of the MACE composite plus incident diabetes (5.25 events per 1,000 person-years). Using a cut-off value of 88.85 cm in men (sensitivity = 0.565) and 85.65 cm in women (sensitivity = 0.558) resulted in the highest value for the prediction of the main outcome. These values were associated with a 1.76 and 1.41-fold increased risk of presenting the composite outcome in men and women, respectively. Conclusions: We defined WC cut-off points of 89 cm in men and 86 cm in women to identify the elevated risk of MACE and incident diabetes. Therefore, we suggest using these values in cardiovascular risk assessment in Latin America.
KW - abdominal obesity
KW - diabetes
KW - Latin America
KW - major cardiovascular events
KW - waist circumference
UR - http://www.scopus.com/inward/record.url?scp=85176385078&partnerID=8YFLogxK
U2 - 10.3389/fcvm.2023.1204885
DO - 10.3389/fcvm.2023.1204885
M3 - Artículo Científico
AN - SCOPUS:85176385078
SN - 2297-055X
VL - 10
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
M1 - 1204885
ER -